4-N-[7-chloro-2-[2-(2-chlorophenyl)ethenyl]quinolin-4-yl]-1-N,1-N-diethylpentane-1,4-diamine | 10023-54-8

• 物质功能分类: 原料药 - 抗寄生虫病药
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4-N-[7-chloro-2-[2-(2-chlorophenyl)ethenyl]quinolin-4-yl]-1-N,1-N-diethylpentane-1,4-diamine
• CAS: 10023-54-8
• 化学式: C₂₆H₃₁Cl₂N₃
• 分子量: 456.4
• InChiKey: CMLVHSVFSYNMGM-UHFFFAOYSA-N

物化性质

• 熔点：
  223-225°
• 沸点：
  597.1±50.0 °C(Predicted)
• 密度：
  1.191±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（升温时高达25mg/ml）。

计算性质

• 辛醇/水分配系数(LogP)：
  7.7
• 重原子数：
  31
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  28.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2922509090

文献信息

• TREATMENTS FOR NEUROPATHY WITH XIB4035
  申请人：Children's Medical Center Corporation

  公开号：EP2240177B1

  公开（公告）日：2016-12-28
• TREATMENTS FOR NEUROPATHY
  申请人：Corfas Gabriel

  公开号：US20090203735A1

  公开（公告）日：2009-08-13

  Small fiber neuropathy is treated or prevented by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat or prevent neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.
• Treatments for Neuropathy
  申请人：Corfas Gabriel

  公开号：US20110086878A1

  公开（公告）日：2011-04-14

  Small fiber neuropathy is treated or prevented by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat or prevent neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.
• COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY
  申请人：CHILDEREN'S MEDICAL CENTER CORPORATION

  公开号：US20160045487A1

  公开（公告）日：2016-02-18

  The invention features XIB4035 for the treatment of large fiber neuropathy, and combinations of XIB4035 and GDNF for the treatment of both large and small fiber neuropathies.
• US7863295B2
  申请人：——

  公开号：US7863295B2

  公开（公告）日：2011-01-04